Roy D. Baynes, Director at Travere Therapeutics, Inc. (TVTX), sold 10,000 shares at $33.00 ($330K) on 2026-04-06, disclosed to the SEC on 2026-04-07.
Scheduled sale ($330k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-05-04 | $431K | — | Filing → |
| TVTX | SELL | 2026-04-16 | $1.4M | — | Filing → |
| NTRA | SELL | 2025-11-21 | $4.6M | — | Filing → |